Judge’s Order Will Expedite Victims’ Actos Bladder Cancer Lawsuits

The Actos Resource Center is the Web’s largest source for information on Actos warnings, research, side effects and legal news. Visit http://www.ActosCancer.com

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend

Actos lawsuit

Quote startWarning that Actos may be associated with a higher risk of bladder cancer.Quote end

Orlando, FL (PRWEB) June 22, 2012

The Actos Resource Center, a patient advocacy group, is alerting patients who suffered injury after taking the diabetes drug Actos of a recent change in court procedures which may streamline the process for them to file a claim for their loss.

The announcement comes nearly a year after the FDA’s June 15, 2011 warning that Actos may be associated with a higher risk of bladder cancer. According to The Canadian Press on April 19, 2012, Health Canada joined the U.S., France, Germany and the European Medicines Agency in also issuing an Actos bladder cancer warning.

Hundreds of people have now contacted the Actos Resource Center to learn about their legal options after suffering bladder cancer, heart attacks or liver damage.

According to a Bloomberg report, Takeda faces thousands of Actos lawsuits from patients in the U.S. In an article published March 13, 2012, the news agency predicted as many as 10,000 patients may eventually file an Actos bladder cancer lawsuit.

In December, a federal Judicial Panel on Multidistrict Litigation issued an order consolidating all lawsuits to a federal court in Louisiana. The case is known as In Re: Actos Products Liability Litigation, MDL 2299, U.S. District Court, Western District of Louisiana (Lafayette).

United States District Judge Rebecca Doherty, who is overseeing the litigation, recently signed a direct-filing order for any new Actos lawsuits. This means that new victims that wish to file an Actos lawsuit in the MDL can do so directly, without first having to file a case in their local court and waiting for it to be transferred to the MDL.

The Actos Resource Center believes this order will expedite the litigation process for new victims and allow the potential cases to reach court or resolution even quicker. Currently, lawyers are helping those patients who took Actos and suffered bladder cancer, heart injury or liver damage.

The MDL is also a more beneficial legal setup than an Actos class action lawsuit since it allows Actos victims to share evidence and resources, while still maintaining separate cases and individual awards.

The Actos Resource Center recommends that anyone diagnosed with bladder cancer after taking Actos speak a lawyer about their legal options. The Actos Bladder Cancer Center only works with Actos lawyers who are actively involved in this litigation and have handled thousands of cases.

For more information on the research, actos warnings, side effects and legal options relating to the drug Actos, or to speak with a lawyer, visit http://www.ActosCancer.com.


Contact